Ofev — Medicare Part D Spending

Generic: Nintedanib Esylate | Manufacturer: Overall

2023 Spending

$1.8B

2023 Claims

140,681

2023 Beneficiaries

20,444

Cost/Unit (2023)

$220.84

5-Year Spending Trend (2019-2023)

Year	Total Spending	Claims	Beneficiaries	Cost/Unit
2019	$789.5M	77,655	11,970	$171.58
2020	$1.2B	105,327	15,902	$183.85
2021	$1.5B	129,070	19,476	$196.36
2022	$1.8B	143,756	20,686	$207.46
2023	$1.8B	140,681	20,444	$220.84

5Y CAGR (cost/unit): 6.5%YoY Change (2022-2023): 6.5%

Spending by State

State	Total Drug Cost	Claims	Prescribers	Beneficiaries
California	$199.2M	15,391	782	2,323
Texas	$168.6M	12,832	555	1,908
Florida	$141.6M	10,767	567	1,609
New York	$120.0M	8,889	549	1,402
Pennsylvania	$78.1M	6,119	369	921
Michigan	$67.0M	5,325	248	769
Illinois	$65.1M	4,878	266	744
Ohio	$64.2M	4,992	308	738
North Carolina	$62.9M	4,811	229	675
Georgia	$62.4M	4,778	226	649
New Jersey	$48.2M	3,709	235	564
Massachusetts	$43.1M	3,310	245	500
Virginia	$41.8M	3,145	170	451
Indiana	$41.3M	3,255	183	476
Arizona	$41.2M	3,174	168	495
Tennessee	$39.1M	3,015	175	475
South Carolina	$38.9M	2,973	138	433
Missouri	$36.4M	2,752	141	394
Kentucky	$35.5M	2,781	148	409
Washington	$32.0M	2,389	150	337
Colorado	$29.4M	2,267	126	337
Alabama	$28.3M	2,244	112	334
Connecticut	$27.9M	2,062	115	309
Louisiana	$26.2M	2,011	124	307
Puerto Rico	$25.1M	2,039	88	294
Wisconsin	$21.9M	1,689	123	245
Oklahoma	$21.8M	1,673	79	256
Minnesota	$21.8M	1,680	102	244
Maryland	$20.1M	1,538	102	231
Mississippi	$18.2M	1,377	78	208
Oregon	$17.1M	1,301	76	191
Arkansas	$16.3M	1,239	69	191
Kansas	$15.3M	1,191	45	182
Iowa	$14.3M	1,102	65	155
Nevada	$13.8M	1,041	56	155
West Virginia	$11.8M	909	56	140
Utah	$11.4M	860	50	130
New Mexico	$8.7M	664	37	97
Nebraska	$8.0M	599	47	82
Maine	$7.6M	560	34	94
Idaho	$7.5M	557	37	80
Vermont	$6.3M	420	15	65
New Hampshire	$5.8M	420	39	69
Rhode Island	$4.2M	312	27	52
Hawaii	$4.1M	338	21	55
Montana	$4.1M	310	19	40
Delaware	$3.1M	230	17	40
Alaska	$2.4M	148	7	22
District of Columbia	$2.3M	177	14	28
North Dakota	$2.3M	171	14	23
South Dakota	$1.7M	137	16	24
Wyoming	$315.9K	25	3	N/A

📊

DrugPricePeek Editorial TeamData Specialists

The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.

✓ Sourced from CMS NADAC & Medicare Part D✓ Quarterly review✓ No paid placements

Read our full methodology or contact us with corrections.

Frequently Asked Questions

How much does Medicare spend on Ofev?

In 2023, Medicare Part D spent $1.8B on Ofev (Nintedanib Esylate), serving 20,444 beneficiaries across 140,681 claims.

What is the cost per unit of Ofev under Medicare?

The weighted average cost per dosage unit of Ofev was $220.84 in 2023. The 5-year compound annual growth rate (2019-2023) was 6.5%.

Who manufactures Ofev?

Ofev (generic name: Nintedanib Esylate) is manufactured by Overall. There are 1 manufacturer(s) listed in the CMS database for this drug.

Is Ofev covered by Medicare Part D?

Yes, Ofev is included in Medicare Part D spending data, indicating it is covered by Part D plans. However, specific coverage and tier placement vary by plan. Check with your specific Part D plan for formulary details.

Where does this Medicare spending data come from?

All Medicare Part D spending data comes from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Spending by Drug dataset, which is publicly available at data.cms.gov.

Explore the DataPeek Network

VocabWize VocabLibre DicionarioWize WortWize KalimaWize KotobaPeek NameBlooms WagePeek NetPayPeek SalaryByCity CostByCity BizTaxWize

Year

Total Spending

Claims

Beneficiaries

Cost/Unit

2019

$789.5M

77,655

11,970

$171.58

2020

$1.2B

105,327

15,902

$183.85

2021

$1.5B

129,070

19,476

$196.36

2022

$1.8B

143,756

20,686

$207.46

2023

$1.8B

140,681

20,444

$220.84

Spending by State

State	Total Drug Cost	Claims	Prescribers	Beneficiaries
California	$199.2M	15,391	782	2,323
Texas	$168.6M	12,832	555	1,908
Florida	$141.6M	10,767	567	1,609
New York	$120.0M	8,889	549	1,402
Pennsylvania	$78.1M	6,119	369	921
Michigan	$67.0M	5,325	248	769
Illinois	$65.1M	4,878	266	744
Ohio	$64.2M	4,992	308	738
North Carolina	$62.9M	4,811	229	675
Georgia	$62.4M	4,778	226	649
New Jersey	$48.2M	3,709	235	564
Massachusetts	$43.1M	3,310	245	500
Virginia	$41.8M	3,145	170	451
Indiana	$41.3M	3,255	183	476
Arizona	$41.2M	3,174	168	495
Tennessee	$39.1M	3,015	175	475
South Carolina	$38.9M	2,973	138	433
Missouri	$36.4M	2,752	141	394
Kentucky	$35.5M	2,781	148	409
Washington	$32.0M	2,389	150	337
Colorado	$29.4M	2,267	126	337
Alabama	$28.3M	2,244	112	334
Connecticut	$27.9M	2,062	115	309
Louisiana	$26.2M	2,011	124	307
Puerto Rico	$25.1M	2,039	88	294
Wisconsin	$21.9M	1,689	123	245
Oklahoma	$21.8M	1,673	79	256
Minnesota	$21.8M	1,680	102	244
Maryland	$20.1M	1,538	102	231
Mississippi	$18.2M	1,377	78	208
Oregon	$17.1M	1,301	76	191
Arkansas	$16.3M	1,239	69	191
Kansas	$15.3M	1,191	45	182
Iowa	$14.3M	1,102	65	155
Nevada	$13.8M	1,041	56	155
West Virginia	$11.8M	909	56	140
Utah	$11.4M	860	50	130
New Mexico	$8.7M	664	37	97
Nebraska	$8.0M	599	47	82
Maine	$7.6M	560	34	94
Idaho	$7.5M	557	37	80
Vermont	$6.3M	420	15	65
New Hampshire	$5.8M	420	39	69
Rhode Island	$4.2M	312	27	52
Hawaii	$4.1M	338	21	55
Montana	$4.1M	310	19	40
Delaware	$3.1M	230	17	40
Alaska	$2.4M	148	7	22
District of Columbia	$2.3M	177	14	28
North Dakota	$2.3M	171	14	23
South Dakota	$1.7M	137	16	24
Wyoming	$315.9K	25	3	N/A

Frequently Asked Questions

How much does Medicare spend on Ofev?

In 2023, Medicare Part D spent $1.8B on Ofev (Nintedanib Esylate), serving 20,444 beneficiaries across 140,681 claims.

What is the cost per unit of Ofev under Medicare?

The weighted average cost per dosage unit of Ofev was $220.84 in 2023. The 5-year compound annual growth rate (2019-2023) was 6.5%.

Who manufactures Ofev?

Ofev (generic name: Nintedanib Esylate) is manufactured by Overall. There are 1 manufacturer(s) listed in the CMS database for this drug.

Is Ofev covered by Medicare Part D?

Where does this Medicare spending data come from?

All Medicare Part D spending data comes from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Spending by Drug dataset, which is publicly available at data.cms.gov.